A new approach to treating gum disease is flipping conventional oral care on its head. Instead of killing all bacteria in your mouth, researchers at the Fraunhofer Institute have created a toothpaste that specifically disarms the harmful microbes responsible for periodontitis while leaving your beneficial bacteria intact. This targeted strategy allows your mouth's natural defenses to rebuild and maintain a healthier balance.

Why Does Your Mouth Need Good Bacteria?

Your mouth is home to more than 700 types of bacteria, but only a small number actually cause problems. The harmful ones collect in dental plaque along the gum line, triggering inflammation known as gingivitis. If left untreated, this inflammation can progress into chronic periodontitis, leading to gum recession and tooth loss. The stakes extend far beyond your smile. When disease-causing bacteria enter the bloodstream, they may contribute to serious conditions including diabetes, rheumatic disease, arthritis, cardiovascular disease, chronic inflammatory bowel disease, and even Alzheimer's disease.

Traditional oral care products like alcohol-based mouthwashes and chlorhexidine solutions kill harmful bacteria effectively, but they also destroy the beneficial microbes your mouth needs. After treatment, your oral microbiome has to rebuild from scratch. During this recovery period, harmful bacteria like Porphyromonas gingivalis often regain dominance quickly because they thrive in inflamed gum tissue, while beneficial bacteria grow more slowly. This imbalance, called dysbiosis, allows the disease to return.

How Does This New Toothpaste Work Differently?

Researchers identified a compound called guanidinoethylbenzylamino imidazopyridine acetate that prevents harmful bacteria from growing rather than killing them outright. This distinction matters enormously. By inhibiting the growth of pathogens like Porphyromonas gingivalis, the compound prevents these bacteria from exerting their toxic effects, allowing beneficial bacteria to occupy spaces that would otherwise remain inaccessible.

"Rather than simply killing gingivitis pathogens, it inhibits their growth. They are unable to exert their toxic effects, so beneficial bacteria can occupy niches that would otherwise be inaccessible to them. In this way, the substance works in harmony with healthy bacteria to gently rebuild and stabilize the microbial balance in the mouth," explained Stephan Schilling, Head of the Fraunhofer IZI branch Molecular Drug Biochemistry and Therapy Development.

Stephan Schilling, Head of the Fraunhofer IZI branch Molecular Drug Biochemistry and Therapy Development

The underlying technology was first developed through an EU-funded research project involving international partners. In 2018, PerioTrap Pharmaceuticals GmbH was established to turn this discovery into practical oral care solutions. Working closely with Fraunhofer IZI and the Fraunhofer Institute for Microstructure of Materials and Systems (IMWS), the team created a toothpaste designed to support the oral microbiome while preventing periodontitis.

What Makes This Product Different From Regular Toothpaste?

Transforming the compound into a usable ingredient required extensive testing to ensure it blocked harmful bacteria effectively while remaining safe for everyday use. The final product could not be toxic, enter the bloodstream, or cause tooth discoloration. Fraunhofer IZI researchers carried out biochemical and structural studies to understand how the substance works and fine-tune the formulation.

Like conventional toothpaste, the new formula also contains abrasives and fluoride to prevent tooth decay. Fraunhofer IMWS contributed by evaluating how different formulations interact with teeth and gums using advanced tools such as scanning electron microscopy and chemical analysis.

"Scanning electron microscopy, chemical characterization and quantitative measurements enable us to draw detailed conclusions about a substance's compatibility and function. To put it simply: We ultimately find out whether the toothpaste works or not," noted Andreas Kiesow, Group Manager Characterization of Medical and Cosmetic Care Products.

Andreas Kiesow, Group Manager Characterization of Medical and Cosmetic Care Products

All testing followed Good Laboratory Practice (GLP) standards, ensuring that results meet strict national and international requirements. This means the product was developed to medical-grade standards, not just as a consumer toothpaste.

How to Support Your Gum Health With New Treatment Options

• Targeted Toothpaste: Use the new formulation that blocks harmful bacteria while preserving beneficial microbes, allowing your oral microbiome to naturally rebalance itself without the disruption caused by traditional antimicrobial products.
• Professional Cleanings Plus: A gel developed for use after professional dental cleanings helps block harmful bacteria and support a healthy microbiome, maintaining gum health between appointments.
• Comprehensive Oral Care: Additional products in development, including a mouthwash and other oral care solutions, will provide multiple ways to maintain microbial balance throughout your daily routine.

Work on the technology is continuing beyond toothpaste. Researchers and the PerioTrap team have developed a gel used after professional dental cleanings to block harmful bacteria, support a healthy microbiome, and maintain gum health. More products are in development, including a mouthwash and other oral care solutions. There is also potential for use in veterinary care, since gum disease in dogs and cats has similar underlying causes.

This innovation represents a fundamental shift in how we think about fighting oral disease. Rather than waging chemical warfare against all bacteria in your mouth, the new approach works with your body's natural defenses to restore balance. For people struggling with gum disease or those seeking to prevent it, this targeted strategy offers a gentler, more effective alternative to traditional treatments that disrupt the delicate ecosystem your mouth depends on.